Chair of Oncology inducted into Order of Canada

A renowned breast cancer researcher and Chair of Oncology at the Michael G. DeGroote School of Medicine has been inducted into the Order of Canada.

May 16, 2017

Order of Canada Investiture Ceremony
Mark Levine, left, with Governor General David Johnston in Ottawa.

A renowned breast cancer researcher and Chair of Oncology at the Michael G. DeGroote School of Medicine has been inducted into the Order of Canada.

Mark Levine was inducted as a Member of the Order May 12 by Governor General David Johnston in a ceremony in Ottawa.

Throughout his career, Levine has been an active researcher in clinical trials and health services research. His focus is in the areas of breast cancer and venous thromboembolism. Numerous clinical trials he has conducted have impacted health care in Canada and internationally.

A first-generation Canadian, Levine told the Hamilton Spectator that his parents were extremely excited about the investiture, which was announced last year.

“My mother made the most deal…she said there was a reason for her to have left Poland, so her son could get the Order of Canada…she cried.”

An illustration of a person supporting a patient using crutches against a showing a ticker counting days and hours.

New research paves the way to recovery for patients in rehabilitation

Berk Görgülü’s research reveals how understanding patient flow and making smarter admission decisions can improve rehabilitation care.
Two researchers examining bacteria on a Petri dish in a laboratory.

One-two punch: McMaster phage researchers uncover new way to disarm dangerous bacteria  

The findings reinforce the potential of phage-based approaches for fighting infections and reveal a broad new vulnerability in bacteria. 
Matthew Miller, the scientist featured in this story, examining vaccine technology in a laboratory.

McMaster Professor Matthew Miller receives national award for excellence in vaccine research

Miller will use the new funding to support the development of next-generation inhaled vaccines that prevent respiratory infections caused by viruses with epidemic and pandemic potential.